SENSEX NIFTY
Ranbaxy Laboratories Half Yearly Results, Ranbaxy Laboratories Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Half Yearly Results - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 19, 16:30
617.45
-3.1 (-0.5%)
VOLUME 45,990
LIVE
NSE
Dec 19, 16:30
617.95
-2.3 (-0.37%)
VOLUME 665,598
Download Annual Report PDF Format 2014 | 2011 | 2010

Half Yearly Results of Ranbaxy Laboratories

------------------- in Rs. Cr. -------------------
Sep '14 Dec '13 Jun '13 Dec '12 Jun '12
Net Sales/Income from operations 3,389.67 2,709.48 2,722.97 2,829.47 3,282.98
Other Operating Income 97.64 82.92 97.55 81.71 109.39
Total Income From Operations 3,487.31 2,792.40 2,820.52 2,911.17 3,392.37
EXPENDITURE
Consumption of Raw Materials 616.67 860.24 810.22 785.61 751.16
Purchase of Traded Goods 411.27 403.59 354.28 399.71 409.30
Increase/Decrease in Stocks 203.91 -153.36 -25.06 -41.94 -7.31
Power & Fuel -- -- -- -- --
Employees Cost 534.41 539.58 508.88 514.79 504.80
Depreciation 125.80 140.25 89.94 90.75 95.41
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 950.33 1,310.26 1,291.11 1,109.42 1,417.53
P/L Before Other Inc. , Int., Excpt. Items & Tax 644.92 -308.17 -208.84 52.83 221.50
Other Income 45.78 64.95 83.37 124.82 114.78
P/L Before Int., Excpt. Items & Tax 690.70 -243.22 -125.47 177.65 336.27
Interest 278.74 229.47 206.73 116.91 180.07
P/L Before Exceptional Items & Tax 411.97 -472.70 -332.20 60.74 156.20
Exceptional Items -15.86 -765.50 -206.46 -126.59 -254.64
P/L Before Tax 396.10 -1,238.19 -538.66 -65.85 -98.44
Tax 9.24 -- -- -1.94 --
P/L After Tax from Ordinary Activities 386.87 -1,238.19 -538.66 -63.90 -98.44
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 386.87 -1,238.19 -538.66 -63.90 -98.44
Equity Share Capital 211.95 211.55 211.55 211.46 211.06
Reserves Excluding Revaluation Reserves -- -- -- 1,709.51 --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 9.13 -- -12.74 -- -2.33
Diluted EPS 9.11 -- -12.74 -- -2.33
EPS After Extra Ordinary
Basic EPS 9.13 -- -12.74 -- -2.33
Diluted EPS 9.11 -- -12.74 -- -2.33
Public Share Holding
No Of Shares (Crores) 14.93 14.80 14.57 14.52 14.50
Share Holding (%) 35.22 34.93 34.43 34.34 34.35
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 26.87 26.87 26.87 26.87 26.87
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) 63.37 63.41 63.51 63.54 63.66
Notes
Source : Dion Global Solutions Limited
Quick Links for ranbaxylaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.